cleveland071708
On the homepage
NewsBreak
Out There
Local
Tour de France
Cleveland-Cliffs makes deal for coal giant Alpha
Print this story
E-mail this story
Save to del.icio.us
Share on Facebook
Share on Digg
Minnesota business by the numbers
See Minnesota's top earning companies, CEOs and non-profits
More from Business
Iron ore giant Cleveland-Cliffs Inc., which has extensive taconite holdings on Minnesota's Iron Range, sought to expand its mining empire Wednesday with an agreement to acquire Appalachian coal giant Alpha Natural Resources for $10 billion.
The stock-and-cash transaction will create one of the largest mining operations in the country and bring coal and iron ore -- key ingredients for making steel -- under one U.S. company. The combined entity will be called Cliffs Natural Resources, and will boast combined revenue of $6.5 billion and $1.9 billion in earnings.
The deal is the latest in a string of moves designed to shore up Cleveland-Cliffs' North American coal and mining operations amid soaring global demand for steel and iron.
Under the terms of the agreement, Alpha stockholders will receive 0.95 shares of Cleveland-Cliffs stock plus $22.23 in cash for each Alpha share they hold. Based on Cleveland-Cliffs' closing stock price Monday, Alpha stockholders would receive $121.05 per share, which amounts to a 27.5 percent premium over Alpha's closing price Tuesday.
Cleveland-Cliffs stock fell $7.44 Wednesday, or 6.7 percent, to 104.02 per share. Shares of Abingdon, Va.-based Alpha Natural rose $10.01, or 10.5 percent, to $104.93.
Dee DePass • 612-673-7725
- GM exits bankruptcy; CEO vows better performance
- Mall, teen store sales decline
- Twin Cities advisers accused of fraud, mismanagement
- Supervalu CEO clears space on executive shelf
- Smith & Hawken to close its doors in Edina
- Oil below $60 as earnings season opens
- AIG, which received $180B in bailouts, asks White House to OK millions in bonuses
Blog: Patent Pending
Farewell VitalMedix
It’s official. VitalMedix Inc., the promising University of Minnesota drug startup, is leaving for Wisconsin. The company, which is developing a hemorrhagic shock drug designed to keep patients alive even after catastrophic blood loss, hasn’t been able to find investors in Minnesota. Wisconsin, on the other hand, boasts a thriving angel investor community thanks to generous [...]
Comment on this story | Be the first to comment | Hide reader comments